Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shari Goldfarb

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 3, 2020
A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivorsJeanne Carter, Raymond E Baser, Deborah J Goldfrank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerChau Dang, Neil Iyengar, Farrah Datko, et al.
Breast Cancer Research and Treatment|March 17, 2006
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspectiveArti Hurria, Shari Goldfarb, Carol Rosen, et al.
Journal of the American College of Radiology : JACR|March 26, 2026
ACR Appropriateness Criteria® Breast Imaging During Lactation, Basak E Dogan, Lonie R Salkowski, et al.
JAMA Network Open|November 28, 2019
Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical TrialNeil M Iyengar, Lillian M Smyth, Diana Lake, et al.
Clinical Breast Cancer|February 12, 2014
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancerKomal Jhaveri, Sarat Chandarlapaty, Diana Lake, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 3, 2020
A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivorsJeanne Carter, Raymond E Baser, Deborah J Goldfrank, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerChau Dang, Neil Iyengar, Farrah Datko, et al.
Breast Cancer Research and Treatment|March 17, 2006
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspectiveArti Hurria, Shari Goldfarb, Carol Rosen, et al.
Journal of the American College of Radiology : JACR|March 26, 2026
ACR Appropriateness Criteria® Breast Imaging During Lactation, Basak E Dogan, Lonie R Salkowski, et al.
JAMA Network Open|November 28, 2019
Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical TrialNeil M Iyengar, Lillian M Smyth, Diana Lake, et al.
Clinical Breast Cancer|February 12, 2014
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancerKomal Jhaveri, Sarat Chandarlapaty, Diana Lake, et al.
Pageof 4